These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31258538)

  • 1. Synthetic Lipopeptide Enhances Protective Immunity Against
    Xue RY; Guo MF; Guo L; Liu C; Li S; Luo J; Nie L; Ji L; Ma CJ; Chen DQ; Sun S; Jin Z; Zou QM; Li HB
    Front Immunol; 2019; 10():1372. PubMed ID: 31258538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rOmp22-HpaA fusion protein confers protective immunity against helicobacter pylori in mice.
    Huang X; Xu B; Duan G; Song C
    Curr Microbiol; 2013 Oct; 67(4):487-92. PubMed ID: 23715666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
    Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoprotective effects of Helicobacter pylori UreB and HpaA bivalence recombinant vaccine with inner adjuvant on experimental infection in mice].
    Mao YF; Yan J; Xu Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 34(5):405-11. PubMed ID: 16216050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant HpaA purified from Escherichia coli has biological properties similar to those of native Helicobacter pylori HpaA.
    Lundstrom A; Bolin I; Bystrom M; Nystrom S
    APMIS; 2003 Mar; 111(3):389-97. PubMed ID: 12752218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro study of the biological activities and immunogenicity of recombinant adhesin of Heliobacter pylori rHpaA].
    Chen Y; Wang J; Shi L
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):276-9. PubMed ID: 11798887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens.
    Tobias J; Lebens M; Wai SN; Holmgren J; Svennerholm AM
    Microb Pathog; 2017 Apr; 105():177-184. PubMed ID: 28215587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
    Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
    Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
    Nyström J; Svennerholm AM
    Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice.
    Sun X; Zhang M; El-Zataari M; Owyang SY; Eaton KA; Liu M; Chang YM; Zou W; Kao JY
    PLoS One; 2013; 8(9):e74595. PubMed ID: 24058595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori.
    Flach CF; Svensson N; Blomquist M; Ekman A; Raghavan S; Holmgren J
    Vaccine; 2011 Feb; 29(6):1235-41. PubMed ID: 21147129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against Helicobacter pylori infection by a trivalent fusion vaccine based on a fragment of urease B-UreB414.
    Wang L; Liu XF; Yun S; Yuan XP; Mao XH; Wu C; Zhang WJ; Liu KY; Guo G; Lu DS; Tong WD; Wen AD; Zou QM
    J Microbiol; 2010 Apr; 48(2):223-8. PubMed ID: 20437155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.
    Li B; Chen L; Sun H; Yang W; Hu J; He Y; Wei S; Zhao Z; Zhang J; Li H; Zou Q; Wu C
    Sci Rep; 2015 Oct; 5():14793. PubMed ID: 26434384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the crystal structure of the HpaA adhesin: insights into cell adhesion function and epitope localization of a
    Martini C; Araba V; Beniani M; Armoa Ortiz P; Simmons M; Chalbi M; Mellouk A; El Bakkouri M; Calmettes C
    mBio; 2024 Mar; 15(3):e0295223. PubMed ID: 38376163
    [No Abstract]   [Full Text] [Related]  

  • 16. The mucosal adjuvant effect of plant polysaccharides for induction of protective immunity against Helicobacter pylori infection.
    Liu C; Luo J; Xue RY; Guo L; Nie L; Li S; Ji L; Ma CJ; Chen DQ; Miao K; Zou QM; Li HB
    Vaccine; 2019 Feb; 37(8):1053-1061. PubMed ID: 30665774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1-mediated immunity against Helicobacter pylori can compensate for lack of Th17 cells and can protect mice in the absence of immunization.
    Ding H; Nedrud JG; Blanchard TG; Zagorski BM; Li G; Shiu J; Xu J; Czinn SJ
    PLoS One; 2013; 8(7):e69384. PubMed ID: 23874957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
    Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
    Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.
    Liu W; Tan Z; Xue J; Luo W; Song H; Lv X; Zheng T; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2016 Jul; 100(14):6219-6229. PubMed ID: 26846746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.